Helene Gayle - Colgate Palmolive Independent Director
| CL Stock | USD 87.13 0.92 1.07% |
Director
Dr. Helene D. Gayle, M.D, is Independent Director of ColgatePalmolive Company. Dr. Gayle has served as President and Chief Executive Officer of The Chicago Community Trust, a community foundation dedicated to improving the Chicago region through strategic grant making, civic engagement and inspiring philanthropy, since October 2017. Dr. Gayle previously served as Chief Executive Officer of McKinsey Social Initiative from 2015 to 2017 and as President and Chief Executive Officer of CARE USA from 2006 to 2015. From 2001 to 2006, she was an executive in the Global Health program at the Bill Melinda Gates Foundation. Dr. Gayle began her career in public health at the U.S. Centers for Disease Control in 1984 and held positions of increasing responsibility over her 20year tenure there, ultimately becoming the director of the National Center for HIV, STD and TB Prevention and achieving the rank of Assistant Surgeon General and Rear Admiral in the United States Public Health Service. Dr. Gayle also serves on the boards of the Center for Strategic and International Studies, the Rockefeller Foundation, New America and the Brookings Institution. She is a member of the Council on Foreign Relations, the National Academy of Medicine and the American Public Health Association. since 2010.
| Age | 64 |
| Tenure | 14 years |
| Professional Marks | Ph.D |
| Address | 300 Park Avenue, New York, NY, United States, 10022-7499 |
| Phone | 212 310 2000 |
| Web | https://www.colgatepalmolive.com |
Colgate Palmolive Management Efficiency
The company has Return on Asset (ROA) of 0.1534 % which means that for every $100 of assets, it generated a profit of $0.1534. This is way below average. Likewise, it shows a return on total equity (ROE) of 2.785 %, which means that it produced $2.785 on every 100 dollars invested by current stockholders. Colgate Palmolive's management efficiency ratios could be used to measure how well Colgate Palmolive manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is expected to rise to 3.97 this year, although the value of Return On Tangible Assets will most likely fall to 0.15. At this time, Colgate Palmolive's Intangible Assets are quite stable compared to the past year. Other Assets is expected to rise to about 1.3 B this year, although the value of Non Current Assets Total will most likely fall to about 6.7 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Paul Fribourg | Estee Lauder Companies | 66 | |
| Aerin Lauder | Estee Lauder Companies | 44 | |
| Charlene Barshefsky | Estee Lauder Companies | 70 | |
| Richard Wolford | ELF Beauty | 75 | |
| Lynn Rothschild | Estee Lauder Companies | 66 | |
| Robert Singer | Coty Inc | 68 | |
| Vittorio Colao | Unilever PLC ADR | 57 | |
| Beth Pritchard | ELF Beauty | 73 | |
| Richelle Parham | ELF Beauty | 53 | |
| Judith Hartmann | Unilever PLC ADR | 51 | |
| Mariasun Larregui | Coty Inc | 57 | |
| Mellody Hobson | Estee Lauder Companies | 48 | |
| AnnaLena Kamenetzky | Coty Inc | N/A | |
| Richard Zannino | Estee Lauder Companies | 61 | |
| Wei Christianson | Estee Lauder Companies | 64 | |
| Rose Bravo | Estee Lauder Companies | 69 | |
| Mary Ma | Unilever PLC ADR | 65 | |
| Louise Fresco | Unilever PLC ADR | 64 | |
| John Rishton | Unilever PLC ADR | 63 | |
| Olivier Goudet | Coty Inc | 56 | |
| Hixonia Nyasulu | Unilever PLC ADR | 61 | |
Management Performance
| Return On Equity | 2.79 | ||||
| Return On Asset | 0.15 |
Colgate Palmolive Leadership Team
Elected by the shareholders, the Colgate Palmolive's board of directors comprises two types of representatives: Colgate Palmolive inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Colgate. The board's role is to monitor Colgate Palmolive's management team and ensure that shareholders' interests are well served. Colgate Palmolive's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Colgate Palmolive's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Philip Shotts, Principal Accounting Officer, Vice President Controller | ||
| Makarand Karnataki, Company Secretary and Compliance Officer | ||
| Lauren Richardson, Chief Officer | ||
| John Huston, Senior Vice President - Office of the Chairman | ||
| Jennifer Daniels, Chief Legal Officer and Secretary | ||
| Delia Thompson, Senior Vice President - Investor Relations | ||
| Ian Cook, Executive Chairman of the Board | ||
| Martiny Harris, Independent Director | ||
| Mike Crowe, Chief Officer | ||
| Kimberly Nelson, Independent Director | ||
| Michael Polk, Independent Director | ||
| P Skala, President - Colgate, North America and Global Sustainability | ||
| C Harris, Independent Director | ||
| Paula Davis, VP Officer | ||
| Lisa Edwards, Independent Director | ||
| Valerie Haliburton, Senior Compliance | ||
| Juan Zamorano, President Division | ||
| Stephan Habif, Chief Officer | ||
| John Kooyman, Chief Marketing Officer | ||
| Noel Wallace, Chairman of the Board, President, Chief Executive Officer | ||
| Stephen Sadove, Lead Independent Director | ||
| Stanley III, Chief Officer | ||
| Delano Lewis, Independent Director | ||
| Franck Moison, COO of Emerging Markets and Bus. Devel. | ||
| Daniel Marsili, Senior Vice President - Global Human Resources | ||
| Peter Skala, COO, North America, Europe, Africa/Eurasia and Global Sustainability | ||
| David Foster, Chief Officer | ||
| Nigel Burton, Chief Marketing Officer | ||
| Lorrie Norrington, Independent Director | ||
| Charles Bancroft, Independent Director | ||
| Prabha Parameswaran, Group President Global Innovation Group and Africa-Eurasia | ||
| Fabian Garcia, COO of Global Innovation and Growth - Europe/South Pacific and Hill?s Pet Nutrition | ||
| Helene Gayle, Independent Director | ||
| Pedro Reinhard, Independent Director | ||
| John Faucher, Chief Officer | ||
| Mukul Deoras, President Colgate – Asia | ||
| Ellen Hancock, Independent Director | ||
| Patricia Verduin, Chief Technology Officer | ||
| Gregory Malcolm, Controller VP | ||
| Victoria Dolan, Vice President Corporate Controller | ||
| Richard Kogan, Independent Director | ||
| Justin Skala, President - Colgate, North America and Global Sustainability | ||
| Stanley Sutula, Chief Financial Officer | ||
| John Cahill, Lead Independent Director | ||
| Henning Jakobsen, Chief Financial Officer, Vice President, Controller | ||
| Martin Harris, Director | ||
| Martina HundMejean, Independent Director | ||
| Dennis Hickey, CFO | ||
| John Bilbrey, Independent Director | ||
| Panagiotis Tsourapas, Group President, Latin America, Asia Pacific & Africa-Eurasia | ||
| Sally Massey, Chief Human Resource Officer |
Colgate Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Colgate Palmolive a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 2.79 | ||||
| Return On Asset | 0.15 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.27 % | ||||
| Current Valuation | 79.64 B | ||||
| Shares Outstanding | 821.99 M | ||||
| Shares Owned By Institutions | 83.96 % | ||||
| Number Of Shares Shorted | 11.75 M | ||||
| Price To Earning | 24.43 X | ||||
| Price To Book | 115.87 X |
Pair Trading with Colgate Palmolive
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Colgate Palmolive position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Colgate Palmolive will appreciate offsetting losses from the drop in the long position's value.Moving together with Colgate Stock
| 0.78 | EL | Estee Lauder Companies Sell-off Trend | PairCorr |
| 0.82 | PG | Procter Gamble Earnings Call Today | PairCorr |
Moving against Colgate Stock
| 0.77 | YSG | Yatsen Holding Trending | PairCorr |
| 0.76 | NUS | Nu Skin Enterprises Financial Report 1st of May 2024 | PairCorr |
| 0.66 | EWCZ | European Wax Center Financial Report 8th of May 2024 | PairCorr |
| 0.59 | ACU | Acme United Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Colgate Palmolive could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Colgate Palmolive when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Colgate Palmolive - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Colgate Palmolive to buy it.
The correlation of Colgate Palmolive is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Colgate Palmolive moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Colgate Palmolive moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Colgate Palmolive can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Colgate Palmolive. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Colgate Stock please use our How to buy in Colgate Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Colgate Stock analysis
When running Colgate Palmolive's price analysis, check to measure Colgate Palmolive's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Colgate Palmolive is operating at the current time. Most of Colgate Palmolive's value examination focuses on studying past and present price action to predict the probability of Colgate Palmolive's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Colgate Palmolive's price. Additionally, you may evaluate how the addition of Colgate Palmolive to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Colgate Palmolive's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Colgate Palmolive. If investors know Colgate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Colgate Palmolive listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 144.537 | Dividend Share 1.91 | Earnings Share 2.77 | Revenue Per Share 23.516 | Quarterly Revenue Growth 0.069 |
The market value of Colgate Palmolive is measured differently than its book value, which is the value of Colgate that is recorded on the company's balance sheet. Investors also form their own opinion of Colgate Palmolive's value that differs from its market value or its book value, called intrinsic value, which is Colgate Palmolive's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Colgate Palmolive's market value can be influenced by many factors that don't directly affect Colgate Palmolive's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Colgate Palmolive's value and its price as these two are different measures arrived at by different means. Investors typically determine if Colgate Palmolive is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Colgate Palmolive's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.